Ibn Sina’s Q3 earnings rise 19.74%

The Ibn Sina Pharmaceutical Industry Ltd reported a 19.74 percent increase in its earnings in the third quarter of this year.

In a filing with Dhaka Stock Exchange on Sunday, the company said that its earnings per share (EPS) was Tk2.79 for the Q3 (July-March) of 2021, which was Tk2.33 in the same period a year earlier.

Its EPS was Tk10.92 for July 2020-March 2021 as against Tk9.63 for the same period of the previous year.

Meanwhile, net operating cash flow per share (NOCFPS) of the pharmaceutical company was Tk14.17 for July 2020-March 2021 as against Tk9.54 for the same period of the previous.

Its net asset value (NAV) per share was Tk64.08 as of March 31, 2021, and Tk56.88 as of June 30, 2020.